# Chelation Therapy in Diabetic Patients With Critical Limb Ischemia

> **NCT03424746** · EARLY_PHASE1 · COMPLETED · sponsor: **Mt. Sinai Medical Center, Miami** · enrollment: 11 (actual)

## Conditions studied

- Critical Limb Ischemia
- Peripheral Arterial Disease

## Interventions

- **DRUG:** disodium EDTA

## Key facts

- **NCT ID:** NCT03424746
- **Lead sponsor:** Mt. Sinai Medical Center, Miami
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2019-01-31
- **Final completion:** 2019-02-18
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2019-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03424746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03424746, "Chelation Therapy in Diabetic Patients With Critical Limb Ischemia". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03424746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*